COVID-19 & Diabetes Treatment: Can We Reduce the Risk of Poorer Outcomes in Our Patients with T2D? Is There a Difference Among Anti-Hyperglycemic Agents?

October 1, 2020

A Continuing Medical Education activity presented by the Project ECHO Diabetes in the Time of ...
read more ↘
1 Comment
Login to view comments. Click here to Login